GSK’s high-level management makeover continues as CEO Emma Walmsley oversees changing of the guard
The big shakeup in the inner executive circle around CEO Emma Walmsley is continuing today, with two top appointments at GlaxoSmithKline — and one key exit …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.